Catamaran Bio

Developer of immune cell therapies for the treatment of cancer and immune disorders

placeCambridge, Massachusetts, United States calendar_todayFounded 2020 groups35 employees language catamaranbio.com

Registered entities

Innovation

4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 570 times.

YearFilings
20222
20233
20242
20261

Investor mix

5 investors on record; lead investors include Sofinnova Partners, Lightstone Ventures.

Investor typeCountShare
Venture capital480%
Other / undisclosed120%
Coming soon